Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing

European Journal of Cancer

Volumn 43, Issue 1, 2007, Pages 71-77

  van Oostrom, Iris ^a   Meijers Heijboer, Hanne ^a   Duivenvoorden, Hugo J ^a   Bröcker Vriends, Annette H J T ^b   van Asperen, Christi J ^b   Sijmons, Rolf H ^c   Seynaeve, Caroline ^a   Van Gool, Arthur R ^a   Klijn, Jan G M ^a   Tibben, Aad ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

BRCA1; BRCA2; Genetic screening; Hereditary nonpolyposis colorectal cancer; Psychological adjustment

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN; PROTEIN HNPCC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRCA2 ONCOGENE; CANCER GENETICS; COLORECTAL CANCER; COPING BEHAVIOR; DISTRESS SYNDROME; EMOTIONAL DISORDER; FAMILIAL CANCER; FAMILY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GRIEF; HUMAN; ILLNESS BEHAVIOR; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PARENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOSOCIAL CARE; REGRESSION ANALYSIS; RELATIVE;

ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISCLOSURE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MUTATION; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL;

EID: 33845966391     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.08.023     Document Type: Article

References (30)

1. Rolland J.S., and Williams J.K. Toward a biopsychosocial model for 21st-century genetics. Fam Process 44 (2005) 3-24
2. Broadstock M., Michie S., and Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 8 (2000) 731-738
3. Hopwood P., Keeling F., Long A., Pool C., Evans G., and Howell A. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology 7 (1998) 402-412
4. Coyne J.C., Benazon N.R., Gaba C.G., Calzone K., and Weber B. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 68 (2000) 864-874
5. Esplen M.J., Madlensky L., Butler K., et al. Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 103 (2001) 9-15
6. Coyne J.C., Kruus L., Racioppo M., Calzone K.A., and Armstrong K. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer. Am J Med Genet 116 (2003) 222-228
7. Leventhal H., Leventhal E.A., and Contrada R.J. Self-regulation, health, and behavior: A perceptual-cognitive approach. Psychol Health 13 (1998) 717-733
8. Decruyenaere M., Evers-Kiebooms G., Welkenhuysen M., Denayer L., and Claes E. Cognitive representations of breast cancer, emotional distress and preventive health behavior: a theoretical perspective. Psycho-Oncology 9 (2000) 528-536
9. Rees G., Fry A., and Cull A. A family history of breast cancer: women's experiences from a theoretical perspective. Soc Sci Med 52 (2001) 1433-1440
10. Prigerson H.G., Maciejewski P.K., Reynolds III C.F., et al. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res 59 (1995) 65-79
11. Boelen P.A., Keijser de J., and Bout van den J. Psychometrische eigenschappen van de Rouw Vragenlijst. Gedrag & Gezondheid 29 (2001) 172-185
12. Moss Morris R., Weinman J., Petrie K.J., Horne R., Cameron L.D., and Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health 17 (2002) 1-16
13. Van Dijk S., Otten W., Zoeteweij M.W., et al. Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment. Br J Cancer 88 (2003) 1675-1681
14. Schreurs P.J.G., and van de Willige G. De Utrechtse Copinglijst (1988), Swets & Zeitlinger, Lisse
15. Van Oostrom I., Meijers-Heijboer H., Lodder L.N., et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21 (2003) 3867-3874
16. Buurmeier F.A., and Hermans P.C. Gezins Dimensie Schalen. Handleiding en vragenlijst (1988), Swets & Zeitlinger, Lisse
17. Anderson S.A., and Sabatelli R.M. The Differentiation in the Family System Scale (DIFS). American Journal of Family Therapy 20 (1992) 77-89
18. Horowitz M., Wilner N., and Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 41 (1979) 209-218
19. Van der Ploeg E., Mooren T.T., Kleber R.J., Van der Velden P.G., and Brom D. Construct validation of the Dutch version of the impact of event scale. Psychol Assess 16 (2004) 16-26
20. Chemtob C.M., Tomas S., Law W., and Cremniter D. Postdisaster psychosocial intervention: a field study of the impact of debriefing on psychological distress. Am J Psychiatry 154 (1997) 415-417
21. Van Oostrom I, Meijers-Heijboer EJ, Duivenvoorden HJ, et al. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns [in press].
22. Van Dooren S., Seynaeve C., Rijnsburger A.J., et al. The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer. Breast Cancer Res Treat 89 (2005) 75-80
23. Erblich J., Bovbjerg D.H., and Valdimarsdottir H.B. Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 22 (2000) 53-59
24. Zakowski S.G., Valdimarsdottir H.B., Bovbjerg D.H., et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 19 (1997) 362-369
25. Lodder L.N., Frets P.G., Trijsburg R.W., et al. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks. J Med Genet 36 (1999) 906-913
26. Turner-Cobb J.M., Bloor L.E., Whittemore A.S., West D., and Spiegel D. Disengagement and social support moderate distress among women with a family history of breast cancer. Breast J 12 (2006) 7-15
27. Esplen M.J., Urquhart C., Butler K., Gallinger S., Aronson M., and Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 55 (2003) 427-435
28. Manne S., Audrain J., Schwartz M., Main D., Finch C., and Lerman C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 28 (2004) 211-225
29. Vernon S.W., Perz C.A., Gritz E.R., et al. Correlates of psychological distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 16 (1997) 73-86
30. Claes E., Denayer L., Evers-Kiebooms G., Boogaerts A., and Legius E. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 55 (2004) 265-274